The FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice regulations for active pharmaceutical ingredients.

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a ...

The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...

Good morning! Here are the five things you need to know in local business news to start your busy — and still very cold — ...

The U.S. Food and Drug Administration has warned the ... ingredients at their Genzyme manufacturing plant in Framingham, Massachusetts. On Jan. 15, 2025, a warning letter was sent to Sanofi ...

THURSDAY, Jan. 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has warned the pharmaceutical ... ingredients at their Genzyme manufacturing plant in Framingham, Massachusetts. On ...

The Food and Drug Administration has proposed moving nutrition labels to the front of most packaged foods, aiming to help consumers make healthier choices, officials said. The FDA officially unveiled ...

Terry Hodge would have a tough time caring for the 150 or so elderly women at Bethany Health Care Center without the dozens ...

The US Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients at their ...

A former Massachusetts doctor was indicted by a grand jury Friday on two rape charges, officials said. More than 200 women ...